1. Adalimumab for patients with Crohn's disease complicated by intra-abdominal abscess: a multicentre, prospective, observational cohort study. (22nd February 2019) Authors: Pineton de Chambrun, G; Pariente, B; Seksik, P; Altwegg, R; Vuitton, L; Stefasnescu, C; Nancey, S; Aubourg, A; Serrero, M; Peyrin-Biroulet, L; Filippi, J; Viennot, S; Abitbol, V; Boualit, M; Boureille, A; Moreau, J; Buisson, A; Roblin, X; Nachury, M; Zappa, M Journal: Journal of Crohn's and colitis Issue: Volume 13(2019)Supplement 1 Page Start: S616 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Comparative Risk of Incident Cancer in Patients with Inflammatory Bowel Disease with Prior Non-digestive Malignancy According to Immunomodulator: a Multicentre Cohort Study. (5th May 2022) Authors: Poullenot, F; Amiot, A; Nachury, M; Viennot, S; Altwegg, R; Bouhnik, Y; Abitbol, V; Nancey, S; Vuitton, L; Peyrin-Biroulet, L; Biron, A; Fumery, M; Picon, L; Vidon, M; Reenaers, C; Serrero, M; Savoye, G; Beaugerie, L; Rivière, P; Laharie, D Journal: Journal of Crohn's and colitis Issue: Volume 16:Number 10(2022) Page Start: 1523 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Defining and Assessing the Reproducibility of Crohn's Disease Endoscopic Lesions: A Delphi-like Method from the GETAID. (12th December 2020) Authors: Buisson, A; Filippi, J; Amiot, A; Cadiot, G; Allez, M; Marteau, P; Bouhnik, Y; Pineton de Chambrun, G; Pelletier, A L; Nancey, S; Moussata, D; Attar, A; Blain, A; Vuitton, L; Vernier-Massouille, G; Seksik, P; Nachury, M; Dupas, J L; Laharie, D; Peyrin-Biroulet, L Journal: Journal of Crohn's and colitis Issue: Volume 15:Number 6(2021) Page Start: 1000 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. DOP33 Role of adherent and invasive E. coli in Crohn's Disease: Lessons from the postoperative recurrence model. (21st January 2022) Authors: Buisson, A; Sokol, H; Hammoudi, N; Nancey, S; Treton, X; Nachury, M; Fumery, M; Hébuterne, X; Rodrigues, M; Hugot, J P; Boschetti, G; Stefanescu, C; Wils, P; Seksik, P; Le Bourhis, L; Bezault, M; Sauvanet, P; Pereira, B; Allez, M; Barnich, N Journal: Journal of Crohn's and colitis Issue: Volume 16(2022)Supplement 1 Page Start: i082 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. DOP34 Comparison of the risk of clinical recurrence after ileocolonic resection for Crohn's Disease for modified Rutgeerts' score i2a and i2b categories: Individual patient data meta-analysis. (21st January 2022) Authors: Riviere, P; Pekow, J; Hammoudi, N; Wils, P; De Cruz, P; Wang, C; Mañosa, M; Ollech, J; Allez, M; Nachury, M; Kamm, M; Maya, A; Ferrante, M; Buisson, A; Singh, S; Laharie, D; Momar, D; Fumery, M Journal: Journal of Crohn's and colitis Issue: Volume 16(2022)Supplement 1 Page Start: i083 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. DOP36 Efficacy and safety of vedolizumab in patients with chronic active pouchitis refractory to anti-TNF therapy: Results of a retrospective multicenter study. (21st January 2022) Authors: Sallette, M; Bouhnik, Y; Nachury, M; Bellanger, C; Laharie, D; Amiot, A; Peyrin-Biroulet, L; Roblin, X; Altwegg, R; Buisson, A; Reenaers, C; Bouguen, G; Vuitton, L; Bourreille, A; Gilletta, C; Serrero, M; Hébuterne, X; Filippi, J Journal: Journal of Crohn's and colitis Issue: Volume 16(2022)Supplement 1 Page Start: i084 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. DOP63 Adalimumab for patients with Crohn's disease complicated by intra-abdominal abscess: a multi-centre, prospective, observational cohort study. (22nd February 2019) Authors: Pineton de Chambrun, G; Pariente, B; Seksik, P; Altwegg, R; Vuitton, L; Stefasnescu, C; Nancey, S; Aubourg, A; Serrero, M; Peyrin-Biroulet, L; Filippi, J; Viennot, S; Abitbol, V; Boualit, M; Boureille, A; Moreau, J; Buisson, A; Roblin, X; Nachury, M; Zappa, M Journal: Journal of Crohn's and colitis Issue: Volume 13(2019)Supplement 1 Page Start: S614 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. DOP74 Efficacy of ustekinumab in perianal Crohn's disease: the BioLAP multi-centre observational study. (25th January 2019) Authors: Biron, C; Seksik, P; Nachury, M; Bouhnik, Y; Amiot, A; Viennot, S; Serrero, M; Fumery, M; Allez, M; Siproudhis, L; Buisson, A; Pineton de Chambrun, G; Abitbol, V; Nancey, S; Caillo, L; Plastaras, L; Armengol-Debeir, L; Chanteloup, E; Simon, M; Dib, N Journal: Journal of Crohn's and colitis Issue: Volume 13(2019)Supplement 1 Page Start: S074 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. DOP76 Real-world multicenter comparison of effectiveness between tofacitinib and vedolizumab in patients with Ulcerative Colitis after failure to at least one anti-TNF agent. (21st January 2022) Authors: Buisson, A; Nachury, M; Fumery, M; Guilmoteau, T; Leclerc, E; Altwegg, R; Serrero, M; Mathieu, N; Treton, X; Vuitton, L; Pereira, B; Amiot, A; Bouguen, G Journal: Journal of Crohn's and colitis Issue: Volume 16(2022)Supplement 1 Page Start: i120 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. DOP78 Efficacy of vedolizumab in perianal Crohn's disease: the BioLAP multi-centre observational study. (25th January 2019) Authors: Biron, C; Seksik, P; Nachury, M; Nancey, S; Bouhnik, Y; Serrero, M; Armengol-Debeir, L; Buisson, A; Tran Minh, M-L; Zallot, C; Fumery, M; Bouguen, G; Abitbol, V; Viennot, S; Chanteloup, E; Rajca, S; Dib, N; Peyrin-Biroulet, L; Vuitton, L Journal: Journal of Crohn's and colitis Issue: Volume 13(2019)Supplement 1 Page Start: S077 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗